Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer CellsSoyoung Lee, Seung Woo Cho, Kyunghwan Kim et al.|Cancer Research|2025Cited by 2
Data from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer CellsSoyoung Lee, Seung Woo Cho, Deok‐Beom Jung et al.|Unknown|2025Cited by 0
Table S1 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer CellsSoyoung Lee, Seung Woo Cho, Kyunghwan Kim et al.|Unknown|2025Cited by 0
Figure S6 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer CellsSoyoung Lee, Seung Woo Cho, Kyunghwan Kim et al.|Unknown|2025Cited by 0
Figure S2 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer CellsSoyoung Lee, Seung Woo Cho, Kyunghwan Kim et al.|Unknown|2025Cited by 0